ATLANTA--(BUSINESS WIRE)--September 17-23 is Global Mitochondrial Disease Awareness Week. Mitochondria are in every cell of our body, except red blood cells, and are tiny cellular powerhouses, essential for energy creation in organ systems, like brain, heart and muscles. Approximately 1 in 2,500 adults, teens and children are affected, making mitochondrial disease more common than childhood cancers. Mitochondrial dysfunction is proven to be at the root of many common diseases and conditions that affect young and old, from Autism to Parkinson's, Alzheimer's, some cancers, and it may even be responsible for aging itself. With mitochondrial dysfunction contributing to so many disparate diseases, collaboration across specialties, among clinicians, researchers and pharmaceutical companies is vital. Non-profit organizations, such as ours, are forming partnerships to maximize our work. To learn more about mitochondrial disease, and how you can help progress research and treatment, please visit: www.hopeflies.org; www.mitoaction.org; www.umdf.org.
The Foundation for Mitochondrial Medicine’s mission is to support the development of the most promising research and treatments for the many forms of mitochondrial disease. Treatments for mitochondrial disease could impact cures for Autism, Alzheimer’s, Parkinson’s, muscular dystrophy and more. For more information on FMM-funded research such as functional MRI studies on cognitive fatigue and testing of new drug compounds, visit www.mitochondrialdiseases.org
MitoAction is a nonprofit organization dedicated to improving the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, and clinical research initiatives. For more information, visit www.mitoaction.org.
Founded in 1996, the United Mitochondrial Disease Foundation (UMDF) works to promote research and education for the diagnosis, treatment and cure of mitochondrial diseases and to provide support for affected individuals and families. Since its inception, the UMDF has funded nearly $11.5 million in research, making it the leading non-governmental contributor of grants focused solely on mitochondrial disease. The UMDF, based in Pittsburgh, PA, is a national organization, represented around the world by thousands of members. For more information about mitochondrial disease or the UMDF, visit www.umdf.org